Incidence of side effects using carbon dioxideeoxygen foam for chemical ablation of superficial veins of the lower extremity

European Journal of Vascular and Endovascular Surgery

Volumn 40, Issue 3, 2010, Pages 407-413

  Morrison, N ^a   Neuhardt, D L ^b   Rogers, C R ^a   McEown, J ^a   Morrison, T ^a   Johnson, E ^a   Salles Cunha, S X ^b  

^a Morrison Vein Institute   (United States)

^b CompuDiagnostics Inc ^*  (United States)

Author keywords

Side effects; Ultrasound guided foam sclerotherapy

Indexed keywords

CARBON DIOXIDE; OXYGEN; POLIDOCANOL;

ADULT; AGED; ARTICLE; BURNING SENSATION; CHEST TIGHTNESS; CIRCUMORAL PARESTHESIA; COMPRESSION GARMENT; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOPPLER ECHOGRAPHY; ECHOGRAPHY; FEMALE; HANGOVER; HEADACHE; HEART RATE; HUMAN; LEG PAIN; LEG VARICOSIS; MAJOR CLINICAL STUDY; MALE; METALLIC TASTE; NAUSEA; PERIPHERAL VEIN; PHLEBECTOMY; PRIORITY JOURNAL; PRURITUS; RESPIRATORY TRACT DISEASE; SAPHENOUS VEIN; SCLEROTHERAPY; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TASTE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT CONTRAINDICATION; ULTRASOUND GUIDED FOAM SCLEROTHERAPY; VISUAL DISORDER; VITAL SIGN;

EID: 78649347817     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.04.018     Document Type: Article

References (47)

1. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, et al. Comparison of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830-6.
2. Breu FX, Guggenbichler S, Wollmann JC. 2nd European consensus meeting on foam sclerotherapy 2006, Tegernsee, Germany. VASA 2008;37(S71):3-29. (Pubitemid 351341147)
3. O'Hare JL, Earnshaw JJ. The use of foam sclerotherapy for varicose veins: A survey of the members of the Vascular Society of Great Britain and Ireland. Eur J Vasc Endovasc Surg 2007;34: 232-3.
4. O'Hare JL, Parkin D, Vandenbroeck CP, Earnshaw JJ. Mid term results of ultrasound guided foam sclerotherapy for complicated and uncomplicated varicose veins. Eur J Vasc Endovasc Surg 2008;36:109-13. (Pubitemid 351876148)
5. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomised efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 2008;47:578-84. (Pubitemid 351258277)
6. Creton D, Uhl JF. Foam sclerotherapy combined with surgical treatment for recurrent varicose veins: Short term results. Eur J Vasc Endovasc Surg 2007;33:619-24. (Pubitemid 46577874)
7. Nitecki S, Bass A. Ultrasound-guided foam sclerotherapy in patients with KlippeleTrenaunay syndrome. Isr Med Assoc J 2007;9:72-5. (Pubitemid 46351244)
8. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasoundguided sclerotherapy for varicose veins: Medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 2007;33:116-21. (Pubitemid 44872674)
9. Smith PC. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006;32: 577-83. (Pubitemid 44499463)
10. Darke SG, Baker SJ. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins. Br J Surg 2006;93:969-74. (Pubitemid 44214847)
11. Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: Immediate results. J Endovasc Ther 2006;13:357-64. (Pubitemid 44775212)
12. Masuda EM, Kessler DM, Lurie F, Puggioni A, Kistner RL, Eklof B. The effect of ultrasound-guided sclerotherapy of incompetent perforator veins on venous clinical severity and disability scores. J Vasc Surg 2006;43:551-6.
13. Bergan J, Pascarella L, Mekenas L. Venous disorders: Treatment with sclerosant foam. J Cardiovasc Surg (Torino) 2006;47:9-18.
14. Bountouroglou DG, Azzam M, Kakkos SK, Pathmarajah M, Young P, Geroulakos G. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: Early results of a randomised controlled trial. Eur J Vasc Endovasc Surg 2006;31:93-100. (Pubitemid 43024990)
15. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: History and analysis of safety and complications. Dermatol Surg 2002;28:11-5. (Pubitemid 34101573)
16. Cavezzi A, Frullini A. The role of sclerosant foam in ultrasound guided sclerotherapy of the saphenous veins and of recurrent varicose veins. Aust NZ J Phlebol 1999;3:49-50.
17. Wright D, Gobin JP, Bradbury AW, Coleridge-Smith P, Spoelstra H, Berridge D, et al. Varisolve polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomised controlled trial. Phlebology 2006;21: 180-90. (Pubitemid 44913249)
18. Cabrera J, Redondo P, Becerra A, Garrido C, Cabrera Jr. J, Garcia-Olmedo MA, et al. Ultrasound guided injection of polidocanol micro-foam in the management of venous leg ulcers. Arch Dermatol 2004;140:667-73. (Pubitemid 38747281)
19. Cabrera J, Cabrera Jr. J, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 2003;139:1409-16. (Pubitemid 37433130)
20. Breu FX, Guggenbicher S, Wollman JC. Second European consensus Meeting on foam sclerotherapy. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European consensus Meeting on foam sclerotherapy 2006, Tegernsee, Germany. VASA 2008;37:90-5. (Pubitemid 351341145)
21. Tessari L, Cavezzi A, Frulini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60. (Pubitemid 32107620)
22. Hansen K, Morrison N, Neuhardt DL, Salles-Cunha SX. Transthoracic echocardiogram and transcranial Doppler detection of emboli after foam sclerotherapy of leg veins. J Vasc Ultrasound 2007;31:213-6.
23. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: A multicentre randomised controlled trial with a 2-year follow-up. Eur J Vasc Endovasc Surg 2008;36:366-70.
24. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): A randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008;35:238-45. (Pubitemid 351163086)
25. Alós J, Carreño P, López JA, Estadella B, Serra-Prat M, Marinel-Lo J. Efficacy and safety of sclerotherapy using polidocanol foam: A controlled clinical trial. Eur J Vasc Endovasc Sug 2006; 31:101-7. (Pubitemid 43024991)
26. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: Initial results. Dermatol Surg 2003;12: 1170-5. (Pubitemid 38009913)
27. Bergan J. Sclerotherapy: A truly minimally invasive technique. Perspect Vasc Surg Endovasc Ther 2008;20:70-2.
28. Coleridge Smith P. Saphenous ablation: Sclerosant or sclerofoam? Semin Vasc Surg 2005;18:19-24.
29. Cabrera J, Cabrera Jr. J. Nuevo método de esclerosis en las varices tronculares. Patol Vascul 1995;4:55-73.
30. Eckman DM, Kobayashi S, Li M. Microvascular embolisation following polidocanol microfoam sclerosant administration. Dermatol Surg 2005;31:636-43. (Pubitemid 43093414)
31. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg; 2008 Oct 13 [Epub ahead of print].
32. Redondo P, Cabrera J. Microfoam sclerotherapy. Semin Cutan Med Surg 2005;24:175-83. (Pubitemid 43011384)
33. Neuhardt DL, Morrison N, Salles-Cunha SX. Emboli detection in the middle cerebral artery concurrent with treatment of lower extremity superficial venous insufficiency with foam sclerotherapy (CO2eO2). Congress Syllabus-Abstract Materials of the American College of Phlebology 22nd Annual Congress, Marco Island, FL, USA; Nov 6-9, 2008.
34. Neuhardt DL, Morrison N, Salles-Cunha SX. Emboli detection in the middle cerebral artery during and following foam sclerotherapy (room air) of lower extremity veins. Congress Syllabus-Abstract Materials of the American College of Phlebology 21nd Annual Congress, Tucson, AZ, USA; 2007 Nov 8-11, p.86.
35. Ceulen RP, Bullens-Goessens YI, Pi-VAN DE Venne SJ, Nelemans PJ, Veraart JC, Sommer A. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: Results of a randomised controlled trial with 1-year follow-up. Dermatol Surg 2007;33:276-81. (Pubitemid 46328226)
36. Hamel-Desnos C, Owvry P, Bdenigni J-P, Boitelle G, Schadeck M, Desnos P, et al. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: A randomised, double-blind trial with 2 year-follow-up. 'The 3/1 study'. Eur J Vasc Endovasc Surg 2007;34:723-9. (Pubitemid 350056378)
37. Bush RG, Derrick M, Manjonev D. Major neurological events following foam sclerotherapy. Phlebology 2008;23:189-92.
38. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43: 162-4. (Pubitemid 43083525)
39. Harzheim M, Becher H, Klockgether T. Brain infarct from a paradoxical embolism following a varices operation. Dtsch Med Wochenschr 2000;125:794-6.
40. Sylvoz N, Villier C, Blaise S, Seinturier C, Mallaret M. Polidocanol induced cardiotoxicity: A case report and review of the literature. J Mal Vasc; 2008 Nov 17 [Epub ahead of print].
41. Myers KA, Jolley D. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 2008;36:602-5.
42. Morrison N. Studies on safety of foam sclerotherapy. In: Bergan J, Cheng V, editors. Foam Sclerotherapy: A Textbook. London: Royal Society of Medicine Press; 2008. p. 183-92.
43. Morrison N. Foam sclerotherapy: How to improve results and reduce side effects? Phlebology 2008;34:211-20.
44. Kobus S, Reich-Schupke S, Pindur L, Altmeyer P, Stucker M. Ascending thrombophlebitis after foam sclerotherapy as first symptom of breast cancer. J Dtsch Dermatol Ges; 2008 Nov 18 [Epub ahead of print].
45. Guex J-J, Raymond-Martimbeau P, Simka M, Passariello F. Letter regarding article titled 'Microembolism during foam sclerotherapy of varicose veins' in the New England. J Med Phlebol 2008;23:249.
46. Ceulen RPM, Vernooy K. Reply to letter regarding article titled 'Microembolism during foam sclerotherapy of varicose veins' in the New England. J Med Phlebol 2008;23:250.
47. Ceulen RPM, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008;358:1525-6. (Pubitemid 351482767)